Selective publication of antidepressant trials

New England Journal of Medicine

Volumn 358, Issue 20, 2008, Pages 2180-2182

  De Jonge, Peter ^a   Bockting, Claudi L ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ACCURACY; DRUG EFFICACY; LETTER; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCIENTIFIC LITERATURE;

EID: 43549102885     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc080313     Document Type: Letter

References (8)

1. EH Turner AM Matthews E Linardatos RA Tell R Rosenthal Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 358 2008 252 260
2. J Moncrieff S Wessely R Hardy Active placebos versus antidepressants for depression. Cochrane Database Syst Rev 1 2004 CD003012
3. MA Katzman AC Tricco D McIntosh Paroxetine versus placebo and other agents for depressive disorders: a systematic review and meta-analysis. J Clin Psychiatry 68 2007 1845 1859
4. JW Schoones Improving literature searches. Radiology 243 2007 301 302
5. R Temple SS Ellenberg Placebo-controlled trials and active-control trials in the evaluation of new treatments. 1. Ethical and scientific issues. Ann Intern Med 133 2000 455 463
6. J Mendels R Johnston J Mattes R Riesenberg Efficacy and safety of b.i.d. doses of venlafaxine in a dose-response study. Psychopharmacol Bull 29 1993 169 174
7. Food and Drug Administration. Summary basis of approval for Effexor.
8. MW Otto AA Nierenberg Assay sensitivity, failed clinical trials, and the conduct of science. Psychother Psychosom 71 2002 241 243